Welcome to LookChem.com Sign In|Join Free

CAS

  • or

174074-88-5

Post Buying Request

174074-88-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174074-88-5 Usage

General Description

7-Quinazolinecarboxylic acid, 1,2,3,4-tetrahydro-2,4-dioxo-, Methyl ester is a compound that belongs to the quinazolinecarboxylic acid family. It is also known by its Chemical Abstracts Service (CAS) number 174252-31-7. This chemical is often used in pharmaceutical research and drug development due to its potential medicinal properties. Additionally, the methyl ester form of this compound makes it more stable and suitable for use in various applications. Its key properties and structure make it a valuable chemical for further research and potential medical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 174074-88-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,0,7 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 174074-88:
(8*1)+(7*7)+(6*4)+(5*0)+(4*7)+(3*4)+(2*8)+(1*8)=145
145 % 10 = 5
So 174074-88-5 is a valid CAS Registry Number.

174074-88-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2,4-dioxo-1H-quinazoline-7-carboxylate

1.2 Other means of identification

Product number -
Other names 2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174074-88-5 SDS

174074-88-5Relevant articles and documents

SUBSTITUTED QUINAZOLINE AND PYRIDO-PYRIMIDINE DERIVATIVES

-

Page/Page column 112-113, (2012/05/19)

The present application provides novel substituted quinazoline and pyrido- pyrimidine compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating PI3K and/or mTOR activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. Advantageously, these compounds perform as dual PI3K/mTOR inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 174074-88-5